Stock MMYT MAKEMYTRIP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus MakeMyTrip Limited

Equities

MMYT

MU0295S00016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
67.47 USD -0.07% Intraday chart for MakeMyTrip Limited +10.79% +43.61%
Feb. 21 MakeMyTrip Shares Decline Following Macquarie Downgrade MT
Feb. 21 Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Adjusts Price Target to $60 From $50 MT

Evolution of the average Target Price on MakeMyTrip Limited

Price target over the last 5 years

History of analyst recommendation changes

8c1165c1e.yALfwZytv92A4wGmvI1EhR09ykU4fXNI096eFtX8YAM.sEmngO_H2YT50Uf_0N9zzm0Jsnd7FEZ8vLvTL5iTLmCYZ76Dpd7emeOpQA~94c01d6c823a13225a847b70166e4940

Analyst Recommendations on MakeMyTrip Limited

Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Adjusts Price Target to $60 From $50 MT
Macquarie Downgrades MakeMyTrip to Neutral From Outperform, Raises Price Target to $60 From $50 MT
Citigroup Raises Price Target on MakeMyTrip to $54 From $47, Maintains Buy Rating MT
Citigroup Adjusts Price Target on MakeMyTrip to $45 From $43, Maintains Buy Rating MT
Morgan Stanley Upgrades MakeMyTrip to Overweight From Equalweight, Price Target is $36 MT
UBS Adjusts MakeMyTrip Price Target to $40 From $37, Maintains Buy Rating MT
JPMorgan Starts MakeMyTrip at Overweight With $44 Price Target MT
Macquarie Starts MakeMyTrip at Outperform With $42 Price Target MT
BofA Securities Upgrades MakeMyTrip to Buy from Neutral, Adjusts Price Target to $40 from $33 MT
UBS Double Upgrades MakeMyTrip to Buy From Sell on a Recovering Travel Market, Adjusts Price Target to $37 From $23 MT
Goldman Sachs Lifts Price Target for MakeMyTrip to $39 From $38, Maintains Buy Rating MT
Citigroup Adjusts MakeMyTrip's Price Target to $43 from $42, Keeps Buy Rating MT
Morgan Stanley Resumes Coverage of MakeMyTrip With Overweight Rating, $29 Price Target MT
MAKEMYTRIP : Citigroup Adjusts Price Target on MakeMyTrip to $38 From $34, Reiterates Buy Rating MT
MAKEMYTRIP : Ambit Capital Initiates Coverage on MakeMyTrip With Buy Rating, $37 Price Target MT
MAKEMYTRIP : BofA Securities Upgrades MakeMyTrip to Neutral From Underperform, Adjusts Price Target to $32 From $14 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
67.52 USD
Average target price
66.89 USD
Spread / Average Target
-0.93%
High Price Target
85 USD
Spread / Highest target
+25.89%
Low Price Target
54 USD
Spread / Lowest Target
-20.02%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MakeMyTrip Limited

Macquarie
Citigroup
Morgan Stanley
UBS
JPMorgan Chase
BofA Securities
Goldman Sachs
Ambit Capital

Ratings for MakeMyTrip Limited

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MMYT Stock
  4. Consensus MakeMyTrip Limited